Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: Regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection

Immunology

Volumn 109, Issue 1, 2003, Pages 137-146

  Yeaman, Grant R ^a   Howell, Alexandra L ^b,c,d   Weldon, Sally ^b   Demian, Douglas J ^b   Collins, Jane E ^b   O'Connell, Denise M ^b   Asin, Susana N ^b   Wira, Charles R ^b   Fanger, Michael W ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c VA MEDICAL CENTER   (United States)

^d Research and Development Service (151)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ESTRADIOL; GALACTOSYLCERAMIDE; PROGESTERONE; VIRUS RECEPTOR;

ARTICLE; ENDOMETRIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION SENSITIVITY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIGENS, CD4; DISEASE SUSCEPTIBILITY; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSYLCERAMIDES; HIV INFECTIONS; HIV-1; HUMANS; MENSTRUAL CYCLE; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; UTERUS;

EID: 0038630425     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01623.x     Document Type: Article

References (55)

1. Flaskerud JH, Ungvarski PJ. Overview and update of HIV disease. In: Ungvarski PJ, Flaskerud JH, eds. HIV/AIDS. A Guide to Primary Care Management. Philadelphia: WB Saunders Co, 1999: 1.
2. Pearce-Pratt R, Phillips DM. Studies of adhesion of lymphocytic cells: Implications for sexual transmission of human immunodeficiency virus. Biol Reprod 1993; 48:431.
3. Pedraza MA, del Romero J, Roldan F, Garcia S, Ayerbe MC, Noriega AR, Alcami J. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J Acquit Immune Defic Syndr Hum Retrovirol 1999; 21:120.
4. Cohen CR, Plummer FA, Mugo N et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327.
5. Plummet FA. Heterosexual transmission of human immunodeficiency virus type 1 (HIV). interactions of conventional sexually transmitted diseases, hormonal contraception and H1V-1. AIDS Res Human Retroviruses 1998; 14 (Suppl. 1):S5.
6. Plummer FA, Ball TB, Kimani J, Fowke KR. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett 1999; 66:27.
7. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors, roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657.
8. Delezay O, Koch N, Yahi N, Hammache D, Tourres C, Tamalet C, Fantini J. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS 1997; 11:1311.
9. Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 1999; 117:359.
10. Jordan NJ, Kolios G, Abbot SE, Sinai MA, Thompson DA, Petraki K, Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest 1999; 104:1061.
11. Murdoch C, Monk PN, Finn A. Functional expression of chemokine receptor CXCR4 on human epithelial cells. Immunology 1999; 98:36.
12. Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 1997; 11:S3.
13. + cells. Nature Med 2002; 8:114.
14. Van't Wout A, Kootstra N, Mulder-Kampinga G et al. Macrophagetropic variants initiate human immunodeficiency virus type-1 infection after sexual, parenteral and vertical transmission. J Clin Invest 1994; 94:2060.
15. Berkowitz R, Alexander S, McCune J. Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus. AIDS Res Hum Retroviruses 2000; 16:1039.
16. Harouse J, Gettie A, Tan R, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284:816.
17. Yeaman GR, Guyre PM, Fanger MW et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukocyte Biol 1997; 61:427.
18. + T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 2001; 102:434.
19. White HD, Crassi KM, Givan AL, Stern JE, Green WR, Wira CR. CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause. J Immunol 1997: 37.
20. Weisz-Carrington P, Bardawil W, Cintron J, Duarte B, Farraj M, Buschmann R. Presence of CD4 on normal endometrial epithelium and endometrial line HEC-1-B. FASEB J 1991; 5:A1265.
21. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997; 151:1341.
22. Jones RL, Kelly RW, Critchley HO. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 1997; 12:1300.
23. Arici A, MacDonald P, Casey M. Progestin regulation of interleukin-8 mRNA levels and protein synthesis in human endometrial stromal cells. J Steroid Biochem Mol Biol 1996; 58:71.
24. Kelly RW, Illingworth P, Baldie G, Leask R, Brouwer S, Calder AA. Progesterone control of' interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum Reprod 1994; 9:253.
25. Asin S, Wildt-Perinic D, Mason S, Howell A, Wira C, Fanger M. HIV-1 infection of human uterine epithelial cells: viral shedding and cell contact mediated infectivity. J Infect Dis 2003; in press.
26. Settlage DS, Motoshima M, Tredway DR. Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil Steril 1973; 24:655.
27. Wolner-Hanssen P, Mardh PA. In vitro tests of the adherence of Chlamydia trachomatis to human spermatozoa. Fertil Steril 1984; 42:102.
28. Friberg J, Confino E, Suarez M, Gleicher N. Chlamydia trachomatis attached to spermatozoa recovered from the peritoneal cavity of patients with salpingitis. J Reprod Med 1987; 32:120.
29. James AN, Knox JM, Williams RP. Attachment of gonococci to sperm. Influence of physical and chemical factors. Br J Vener Dis 1976; 52:128.
30. James-Holmquest AN, Swanson J, Buchanan TM, Wende RD, Williams RP. Differential attachment by piliated and nonpiliated Neisseria gonorrhoeae to human sperm. Infect Immun 1974; 9:897.
31. Brogi A, Presentini R, Solazzo D, Piomboni P, Costantino-Ceccarini E. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Human Retroviruses 1996; 12:483.
32. Howard TL. Bacterial hitch-hikers. J Urol 1971; 106:94.
33. Brogi A, Presentini R, Moretti E, Strazza M, Piomboni P, Costantino-Ceccarini E. New insights into the interaction between the gp 120 and the HIV receptor in human sperm (human.sperm/gp120/galactoglycerolipid/ antigalactosylceramide/seminolipid/spermatogonia). J Reprod Immunol 1998; 41:213.
34. Gadella BM, Hammache D, Pieroni G, Colenbrander B, van Golde LM, Fantini J. Glycolipids as potential binding sites for HIV. topology in the sperm plasma membrane in relation to the regulation of membrane fusion. J Reprod Immunol 1998; 41:233.
35. Yahi N, Baghdiguian S, Moreau H, Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J Virol 1992; 66:4848.
36. Yahi N, Sabatier JM, Baghdiguian S, Gonzalez-Scarano F, Fantini J. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J Virol 1995; 69:320.
37. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp 120 receptor. Proc Natl Acad Sci USA 1993; 90:2700.
38. Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 1997; 71:3498.
39. Noyes RW, Hertig AT. Dating the endometrial biopsy. Fertil Steril 1955; 1:3.
40. Motulsky HJ. Analyzing Data with Graphpad Prism. San Diego, CA: GraphPad Software Inc., 1999.
41. Feng Y, Broder C, Kennedy P, Berger E. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872.
42. Deng H, Liu R, Ellmeier W et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996; 381:661.
43. Vassiliadou N, Tucker L. Anderson DJ. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J Immunol 1999; 162:7510.
44. Bonatz G, Hansmann M, Buchholz F, Mettler L, Radzun H, Semm K. Macrophage- and lymphocyte-subtypes in the endometrium during different phases of the ovarian cycle. Int J Gynaecol Obstet 1992; 37:29.
45. Kamat B, Isaacson P. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987; 127:66.
46. Bulmer J, Lunny D, Hagin S. Immunohistochemical characterization of stromal leukocytes in nonpregnant human endometrium. Am J Reprod Immunol Microbiol 1988; 17:83.
47. Givan AL, White HD, Stern JE, Colby E, Guyre P, Wira CR. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix and vagina. Am J Reprod Immunol 1997; 38:350-9.
48. Nelson JD, Jato-Rodriguez JJ, Labrie F, Mookerjea S 1977 Glycosyltransferase and UDP-galactose pyrophosphatase activities in the endometrium during oestrous cycle of the rat. J Endocrinol 1997; 73:53.
49. Kubushiro K, Kojima K, Mikami M, Nozawa S, Iizuka R, Iwamori M, Nagai Y. Menstrual cycle-associated alteration of sulfogalactosylceramide in human uterine endometrium: possible induction of glycolipid sulfation by sex steroid hormones. Arch Biochem Biophysics 1989; 268:129.
50. Sodora D, Gettie A, Miller C, Marx P. Vaginal transmission of SIV. assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retrovimses 1998; 14(Suppl 1):S119-23.
51. Guimaraes MD, Munoz A, Boschi-Pinto C, Castilho EA. HIV infection among female partners of seropositive men in Brazil. Rio de Janeiro Heterosexual Study Group. Am J Epidemiol 1995; 142:538.
52. Marx P, Spira A, Gettie A et al. Progesterone implants enhance SIV vaginal transmission and early vires load. Nature Med 1996; 2:1084.
53. Smith S, Baskin G, Marx P. Estrogen protects against vaginal transmission of simian immunodeficiency vires. J Infect Dis 2000; 182:708.
54. Hocini H, Becquart P, Bouhlal H, Adle-Biassette H, Kazatchkine M, Belec L. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated vires across tight epithelial barriers. Clin Diagn Lab Immunol 2000; 7:515.
55. Fahey J, Wira C. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185:1606.